Explore groundbreaking studies, clinical trial updates, and emerging technologies shaping the future of cancer treatment.
Explore the groundbreaking phase 3 VERIFY trial results for rusfertide, a novel hepcidin mimetic that offers new hope for polycythemia vera patients.